266 related articles for article (PubMed ID: 20193172)
1. [The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy].
Maron MS
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1057-63. PubMed ID: 20193172
[TBL] [Abstract][Full Text] [Related]
2. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
Maron MS
J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
[TBL] [Abstract][Full Text] [Related]
3. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
Maron MS
J Cardiovasc Magn Reson; 2012 Feb; 14(1):13. PubMed ID: 22296938
[TBL] [Abstract][Full Text] [Related]
4. The role of cardiac magnetic resonance in hypertrophic cardiomyopathy.
Duarte S; Bogaert J
Rev Port Cardiol; 2010 Jan; 29(1):79-93. PubMed ID: 20391901
[TBL] [Abstract][Full Text] [Related]
5. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Maron MS; Finley JJ; Bos JM; Hauser TH; Manning WJ; Haas TS; Lesser JR; Udelson JE; Ackerman MJ; Maron BJ
Circulation; 2008 Oct; 118(15):1541-9. PubMed ID: 18809796
[TBL] [Abstract][Full Text] [Related]
7. The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy.
Hoey ET; Teoh JK; Das I; Ganeshan A; Simpson H; Watkin RW
Clin Radiol; 2014 Mar; 69(3):221-30. PubMed ID: 24412355
[TBL] [Abstract][Full Text] [Related]
8. MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside.
Bogaert J; Olivotto I
Radiology; 2014 Nov; 273(2):329-48. PubMed ID: 25340269
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
[TBL] [Abstract][Full Text] [Related]
10. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
Maron MS; Maron BJ; Harrigan C; Buros J; Gibson CM; Olivotto I; Biller L; Lesser JR; Udelson JE; Manning WJ; Appelbaum E
J Am Coll Cardiol; 2009 Jul; 54(3):220-8. PubMed ID: 19589434
[TBL] [Abstract][Full Text] [Related]
11. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations.
Germans T; Wilde AA; Dijkmans PA; Chai W; Kamp O; Pinto YM; van Rossum AC
J Am Coll Cardiol; 2006 Dec; 48(12):2518-23. PubMed ID: 17174192
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy.
Melacini P; Corbetti F; Calore C; Pescatore V; Smaniotto G; Pavei A; Bobbo F; Cacciavillani L; Iliceto S
Int J Cardiol; 2008 Aug; 128(3):364-73. PubMed ID: 17643520
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular magnetic resonance characteristics in children with hypertrophic cardiomyopathy.
Chaowu Y; Shihua Z; Jian L; Li L; Wei F
Circ Heart Fail; 2013 Sep; 6(5):1013-20. PubMed ID: 23873474
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.
Kamal MU; Riaz IB; Janardhanan R
Cardiol J; 2016; 23(3):250-63. PubMed ID: 27064795
[TBL] [Abstract][Full Text] [Related]
17. Management implications of massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance.
Maron MS; Lesser JR; Maron BJ
Am J Cardiol; 2010 Jun; 105(12):1842-3. PubMed ID: 20538141
[TBL] [Abstract][Full Text] [Related]
18. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
[TBL] [Abstract][Full Text] [Related]
19. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
Maron MS; Olivotto I; Harrigan C; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron BJ
Circulation; 2011 Jul; 124(1):40-7. PubMed ID: 21670234
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
